mean arterial pressure increased from 97±4 to 131±5 mm Hg), had much smaller effects on venous blood gases, hemoglobin, and 02 extraction (2.3±0.7 vol%) and no significant effect on 02 consumption. NLA also caused an increase in 02 consumption of 37±8% (P<.01) in quietly resting conscious dogs that had undergone pretreatment with hexamethonium and atropine, but no significant change in 02 consumption in dogs anesthetized with barbiturate. Our results suggest that basal constitutive NO release has an important function in the regulation of tissue oxygenation; perhaps NO production by capillary endothelium regulates mitochondrial function in adjacent parenchymal cells in peripheral tissues.
Role of Nitric Oxide in the Regulation of Oxygen Consumption in Conscious Dogs
Weiqun Shen, Xiaobin Xu, Manuel Ochoa, Gong Zhao, Michael S. Wolin, Thomas H. Hintze
Abstract The role of nitric oxide (NO) in the regulation of 02 consumption was studied in chronically instrumented conscious dogs. A specific NO synthesis inhibitor, nitro-L-arginine (NLA, 30 mg/kg IV), significantly increased mean arterial pressure from 100±4 to 134±5 mm Hg (mean±SEM) and total peripheral resistance by 157±16% and reduced cardiac output by 47±3% and heart rate by 34±6% after 120 minutes. Changes in arterial blood gases were not observed. There were significant changes in Po2 (-14±2 mm Hg), 02 saturation (-21±2%), the percentage of hemoglobin as oxyhemoglobin (-21±2%), and 02 content (-3.0±0.9 vol%) and a significant increase in percent reduced hemoglobin (21±1%) in mixed venous blood, associated with an increase in 02 extraction (5.1±0.2 vol%) (all P<.01). 02 consumption was increased from 124± 6 to 155 ±9 mL/min (P<.05). Methoxamine, titrated to have hemodynamic effects similar to those of NLA (eg, itric oxide (NO) formed during the metabolism N of L-arginine1-3 has been identified as an important endothelium-derived relaxing factor (EDRF), which is released from the endothelium and results in vascular smooth muscle relaxation through a cGMP-dependent mechanism.3-5 NO is also found in the central nervous system, where it may mediate some forms of interneuronal communication. 6 In addition, NO has been found in activated macrophages, where it is responsible for cytotoxicity and its production is induced after cytokine stimulation.7-9 The mechanism for cytotoxicity of activated macrophages is dependent on NO production, which has multiple actions including inhibition of mitochondrial respiration in target cells. Three mitochondrial enzymes are affected by NO: (1) aconitase in the tricarboxylic acid cycle and (2) NADH+-ubiquinone oxidoreductase and (3) succinateubiquinone oxidoreductase, which are part of complex I and complex II of the mitochondrial electron transport chain. [9] [10] [11] It was recently reported that in cultured rat hepatocytes and rat aortic smooth muscle cells, NO production induced by cytokines results in significant inhibition of aerobic energy metabolism through the inhibition of the mitochondrial enzymes. [12] [13] [14] Because all observations of the effects of NO on respiratory function previous to these findings were examined in vitro and involved the induction of NO synthase, which is associated with the production of relatively large local concentrations of NO and with pathophysiological conditions, we wondered whether the constitutive pathways of NO production could regulate tissue metabolism under normal physiological conditions. Therefore, the present study addressed the question whether tissue 02 consumption is modulated physiologically in vivo by NO produced by the constitutive NO synthase.
In the present study, nitro-L-arginine (NLA), a specific NO synthesis inhibitor, was administered to chronically instrumented awake dogs to inhibit NO production, and total tissue 02 consumption was measured to determine whether basal constitutive NO production plays a role in the modulation of tissue metabolism in normal conscious dogs. Because inhibition of NO synthesis in vivo leads to vasoconstriction, reduced cardiac output, and increased arterial pressure, the effects of NLA were compared with those of another vasoconstrictor, methoxamine (MTX), the dose of which was titrated to cause similar increases in arterial pressure and peripheral resistance. To further understand the mechanism of the modulatory action of NO on tissue oxygenation, we measured 02 consumption in conscious dogs after the administration of hexamethonium and atropine to block central sympathetic and parasympathetic outflow. Finally, 02 consumption was measured in dogs anesthetized with a barbiturate, sodium pentobarbital, which inhibits mitochondrial function.
Materials and Methods
The experiments were carried out in chronically instrumented conscious dogs. These adult male mongrel dogs were conditioned to the laboratory environment and supplied with standard dog chow and had free access to water.
Animal and Surgical Preparation
Dogs were sedated with acepromazine (0.3 mg/kg), anesthetized with pentobarbital (25 mg/kg), and artificially venti-lated with a respirator (Harvard), and a thoracotomy was performed in the fifth left intercostal space by using sterile surgical techniques. The pericardium was incised parallel to the phrenic nerve. An electromagnetic flow transducer (445C, 450C, or 455C, Carolina Medical Electronic Inc) was placed on the ascending aorta for measurement of cardiac output, and two catheters (Tygon, Cardiovascular Institute) were implanted in the descending thoracic aorta for measurement of arterial pressure and withdrawal of an aortic blood sample. An additional catheter was implanted near the apex of the right ventricle, because this site is easily accessible from a left thoracotomy and is located as far as possible from the right atrium, so that only well-mixed peripheral venous blood was sampled. The incision was closed in layers and the pneumothorax was reduced. All of the catheters and transducer wires were run subcutaneously and exited between the shoulder blades. The dogs were allowed to recover completely for z10 days. During this period they were given antibiotics and trained to lie quietly on the laboratory table.
Measurements
Cardiac output was measured from the previously placed electromagnetic flow transducer by using a square-wave electromagnetic flowmeter (FM-501, Carolina Medical Electronic Inc) and an 8-Hz low-pass filter. Zero blood flow was set in each experiment with late diastolic blood flow in the aorta used as a reference, because flow is zero at that point in time. In addition, zero flow was checked by causing a 5-to 8-second asystole by means of an injection of acetylcholine (50 ,gtg/kg) at the end of some experiments and also when the dog was killed and the heart stopped. Arterial pressure was measured by connecting the previously implanted aortic catheter to a strain-gauge transducer (Statham P231D), and mean arterial pressure was derived by using 2-Hz low-pass filters. Heart rate was monitored from the pressure pulse interval by using a cardiotachometer (Beckman Instruments). All signals were recorded on a direct-writing oscillograph (Gould 2800).
Arterial and mixed venous blood samples were withdrawn from the previously implanted aortic and right ventricular catheters simultaneously. Blood pH, P02, and Pco2 were measured with a blood gas analyzer (Corning 170) at 37°C, and total hemoglobin (THb), percent O2 saturation, percent oxygenated hemoglobin (%02Hb), and percent reduced hemoglobin (%RHb) were measured with an Instrumentation Laboratories CO-oximeter system (IL4802). These instruments were calibrated daily. The following equations were used: blood O2 concentration= (1.39 x %02Hb) xTHb+ (0.003 xblood P02); 02 extraction =arterial 02 concentration-mixed venous 02 concentration; total 02 consumption=02 extraction x cardiac output. Before infusion of any drug, at least two blood samples were taken for measurement of blood gases, and only when the values were repeatable were experiments begun. We have used all these techniques previously. 15, 16 Experimental Drugs NLA (Aldrich Chemical Co, Inc), a specific EDRF/NO synthesis inhibitor, was dissolved in normal saline at a concentration of 7.0 mg/mL, and a dose of 30 mg/kg was given to dogs intravenously. This dose reduces the vasodilation to acetylcholine by >60% in conscious dogs.15 MTX, a specific a,-adrenergic agonist, was dissolved in normal saline at a concentration of 500 jtg/mL, and a dose of 10 to 20 jig. kg-.min`was given to dogs by intravenous infusion with an infusion withdrawal pump (Harvard) to maintain an elevation of mean arterial blood pressure of ---30 mm Hg above normal. For ganglionic blockade, hexamethonium at a dose of 30 mg/kg was infused by use of an infusion pump for 20 minutes, and atropine methyl bromide at a dose of 0.1 mg/kg was given intravenously during the last 5 minutes of the hexamethonium infusion (n=5). Pentobarbital was given to dogs at a dose of 20 mg/kg IV to induce a surgical level of anesthesia (n=5).
Experimental Protocols
Experiments were performed in conscious dogs, which were assigned randomly to four groups. One group was treated with NLA (n=9), another was treated with MTX (n=7, of which 3 dogs received both NLA and MTX), a third was given NLA after autonomic blockade (n=5), and a fourth was given NLA after pentobarbital anesthesia (n=5). After each dog had lain quietly on the laboratory table for at least 20 minutes, hemodynamics were recorded and control arterial and mixed venous blood samples were withdrawn simultaneously for analysis of blood gases and hemoglobin. NLA was then administered to one group of dogs by intravenous injection and MTX was administered by intravenous infusion to another group. The infusion rate of MTX was adjusted to maintain an elevation of mean arterial pressure of ":30 mm Hg (this was done to approximate the increase in pressure caused by NLA until group means could be calculated) for the duration of the experiment, 120 minutes. In the dogs given NLA, body temperature was measured by an electric thermometer (Yellow Spring Instruments, model 73A).
Additional experiments were performed in conscious dogs that had been given a pretreatment of hexamethonium and atropine (n=5) and in anesthetized dogs that had been given pentobarbital (n=5, of which 4 dogs also received hexamethonium and atropine). After pretreatment for at least 30 minutes and when the dog's hemodynamics and blood gases were stable, the control arterial and mixed venous blood samples were taken. NLA was then administered to both groups by intravenous injection at a dose of 30 mg/kg.
In all of the experiments, blood samples were withdrawn at 5, 15, 30, 60, and 120 minutes after administration of NLA or MTX. Cardiac output, arterial blood pressure, and heart rate were continuously recorded throughout the experiment.
All of the protocols were approved by the Institutional Animal Care and Use Committee of New York Medical College and conform to the National Institutes of Health Guide for the Use and Care of Laboratory Animals and the principles of the American Physiological Society.
Statistical Analysis
Data were sampled before the beginning of treatment and after 5, 15, 30, 60, and 120 minutes of treatment with either NLA or MTX and after autonomic blockade or pentobarbital. All cardiac hemodynamic values were averaged over an entire respiratory cycle. The vascular resistance in tissues and organs was calculated by the following formula: resistance (mm Hg * L`. min ')=mean arterial pressure (mm Hg) . cardiac output (L/ min). All of the data in the text are expressed as mean±SEM, and two-way ANOVA was used to assess the effects of NLA or MTX on total 02 extraction, total 02 consumption, blood gases, hemoglobin, and hemodynamic responses. The ratio of F values was converted to a Student's t distribution using Scheffe's test.
Changes were considered significant at the P<.05 level.
Results
Effects of NLA and MTX on hemodynamics, blood gases, hemoglobin, 02 extraction, and 02 consumption after 5, 15, 30, 60, and 120 minutes are presented in the tables and figures. Only the 60-and 120-minute time points are discussed in detail in the text.
Effects of NLA and MTX on Hemodynamics
Administration of NLA resulted in significant elevations of mean arterial pressure of 32±4% and 33±3% from 100±4 mm Hg and decreases in heart rate by 33±6% and 34+6% from 93±5 beats per minute, respectively (all P<.01), after 60 and 120 minutes ( 43±4% and 47±3% from 3.0±0.2 L/min; these reductions were associated with significant increases in total peripheral resistance of 141±20% and 157±16% from 35±3 mm Hg* L1. min-1, respectively (all P<.01), after 60 and 120 minutes ( Fig 2) . Hemodynamic responses to intravenous infusion of MTX were similar by design to those induced by NLA. After titration of MTX for 60 and 120 minutes, there were significant elevations of mean arterial pressure of 2 ). Effects of NLA on Hemodynamics After Administration of Hexamethonium and Atropine or Pentobarbital After administration of hexamethonium and atropine, there were significant decreases of 14±3% in mean arterial pressure from 99±3 mm Hg and of 10±4% in cardiac output from 3.8±0.3 L/min; heart rate increased significantly by 72± 15% from 78±5 beats per minute. Total peripheral resistance was 25 ± 1 mm Hg* L`min`. After 60 and 120 minutes, NLA administration resulted in significant increases in mean arterial pressure of 55±9 and 37±7 mm Hg from 85±2 mm Hg and significant decreases in cardiac output by 0.8±0.2 and 1.1±0.1 L/min from 3.4 L/min. These changes were associated with significant elevations of total peripheral resistance of 122±19% and 113±12% from 25 ± 1 mm Hg* L`1 min-1, respectively (all P< .01).
Heart rate was maintained at 131 ± 17 and 128±14 beats per minute from 134±13 beats per minute (Table 1 ).
In dogs anesthetized with pentobarbital, the hemodynamic responses to NLA were similar to those in the conscious dogs. After 60 and 120 minutes, NLA administration caused significant increases in mean arterial pressure of 23 ± 10 and 26± 14 mm Hg, respectively, from 106±8 mm Hg and decreases in heart rate of 42±5% and 36±8% from 128± 13 beats per minute; it also resulted in decreases in cardiac output of 43±4% and 48+4% from 3.1 ±0.2 L/min, these latter changes being associated with elevations of total peripheral resistance by 126±28% and 159±37% from 34±2 mm Hg * L1 -min-1, respectively (all P<.01) ( Table 1) .
Effects of NLA and MTX on Blood Gases and Hemoglobin
The effects of NLA and MTX on pH, Po2, and Pco2 in arterial and venous blood are shown in Table 2 . NLA and MTX had no significant influence on blood pH and arterial Po2. There were significant decreases in Po2 in mixed venous blood of 30±3% and 29±3% from 46±1.3 mm Hg (P<.01) 60 and 120 minutes after NLA administration, but no significant changes after MTX administration. Both NLA and MTX administration resulted in significant decreases in arterial blood Pco2 of 10±3% and 9±2% and of 9±3% and 9±2%, respectively (all P<.01), after 60 and 120 minutes, but there was no effect on venous blood Pco2.
The effects of NLA and MTX on hemoglobin in arterial and venous blood are shown in Table 3 . After 60 and 120 minutes, NLA administration resulted in significant reductions of 02 saturation of 30±5% and 29±2% in arterial and venous blood, decreases in the percentage of hemoglobin as oxyhemoglobin of 29±5% and 29±2%, and increases in %RHb of 82±17% and 80±10% in venous blood, respectively (all P<.01) (Figs 3 and 4 ). On the other hand, MTX caused similar but much smaller changes in blood hemoglobin; 60 and 120 minutes of l 1~~~~~~~ 
Effects of NLA on Blood Gases and Hemoglobin After Pentobarbital or Hexamethonium and Atropine
There were no significant differences in blood pH, gases, and hemoglobin in arterial and mixed venous blood after pentobarbital or hexamethonium and atropine pretreatment.
NLA had no significant effect on blood pH or Pco2 or on arterial Po2. After 60 and 120 minutes, NLA administration caused significant decreases in venous Po2 of 17±3% and 27±4%, respectively, from 40 mm Hg in the dogs given hexamethonium and atropine (all P<.01) and decreases of only 11±2% and 15±2%, respectively, from 41 mm Hg in the dogs given pentobarbital (all P<.01). The reductions in venous Po2 induced by NLA after hexamethonium and atropine were greater than those after pentobarbital.
NLA did not cause significant changes in arterial 02 saturation, oxyhemoglobin, or %RHb. After 60 and 120 minutes of treatment, NLA administration resulted in significant reductions of venous 02 saturation of 21+3% and 27 +4%, respectively, and of venous oxyhemoglobin of 21±3% and 28±4%; it also caused significant increases in venous %RHb of 44±6% and 60±15%, respectively (all P<.01), in the dogs given hexamethonium and atropine. NLA administration for 60 and 120 minutes also caused significant decreases in venous 02 saturation of 19±6% and 22±5%, respectively, and in venous oxyhemoglobin of 20±5% and 23±4%, as well as significant increases in venous %RHb of 45±12% and 52±8% (all P<.01), in the dogs that had been given pentobarbital.
Effect of NLA and MTX on 02 Extraction and 02 Consumption
The effects of NLA and MTX on 02 concentration in arterial and venous blood, total 02 extraction, and total 02 consumption are shown in Table 4 . NLA administration resulted in significant increases in total 02 extraction by 122±17% and 134±15% and of total 02 consumption by 22±7% and 25±7% (all P<0.01) after 60 and 120 minutes of treatment, respectively ( Fig 5) . In contrast, MTX administration for 60 and 120 minutes caused significant increases in total 02 extraction of only 47±11% and 50±13% (all P<.01), changes that were much smaller than those induced by NLA. Moreover, there was no significant change in total 02 consumption at any time after MTX administration ( Fig 5) . There was an unexpected increase in oxygen content in arterial and venous blood after either NLA or MTX administration. This was associated with an increase in both arterial hematocrit and THb and may indicate contraction of the spleen, which is an important red blood cell reservoir in the dog. 
Effect of NLA on 02 Extraction and 02
Consumption After Pentobarbital or Hexamethonium and Atropine After 60 and 120 minutes of treatment, NLA administration resulted in significant increases in total 02 extraction of 86+10% and 106±18% and elevation of total 02 consumption by 39±6% and 38±8%, respectively (all P<.01), in the dogs given hexamethonium and atropine. In contrast, NLA caused significant increases in total 02 extraction of only 46±16% and 79±12% (all P<.01) for 60 and 120 minutes, increases that were much smaller than the changes induced by NLA; NLA administration had no effect on total 02 consumption in the dogs given pentobarbital (Fig 6) .
Discussion
The major finding in the present study is that NLA, a specific NO synthesis inhibitor, caused marked elevation of 02 extraction, 02 consumption, and body temperature, associated with significant decreases in Po2, 02 saturation, and oxyhemoglobin and an increase in %RHb in mixed venous blood in conscious dogs. These changes were accompanied by significant increases in mean arterial pressure and total peripheral resistance and by decreases in cardiac output and heart rate. In contrast, MTX had a much smaller effect on mixed venous blood gases, hemoglobin, and 02 extraction and no effect on 02 consumption, despite hemodynamic responses similar to those induced by NLA. In addition, NLA administration still caused a significant increase in 02 consumption in conscious dogs given hexamethonium and atropine and had no effect on 02 consumption in dogs anesthetized with a barbiturate.
With the discovery of the NO synthetic pathway, L-arginine analogues with a chemically altered guanidino moiety have been developed to inhibit the L-arginine-dependent NO synthesis and to assess the function of NO.17-19 A number of studies have shown that NLA is a stereospecific, potent inhibitor of NO production from endothelial cells in vitro and in vivo. [17] [18] [19] The hemodynamic responses induced by NLA in the present study were consistent with previous observations from our laboratory20-22 and those reported from other stud-ies23; among the similarities were the significant increases in mean arterial pressure and total peripheral resistance and the decreases in heart rate and cardiac output. Those hemodynamic changes were an indication of a remarkable inhibitory effect of NLA on NO synthesis and confirm that an important vasodilatory factor is released continuously from endothelium to maintain normal vascular tone.
The most important finding in the present study is that infusion of NLA resulted in a significant elevation of the total tissue 02 consumption. This indicates that NO produced continuously from endothelium may have an inhibitory effect on tissue metabolism. After NLA blocked the synthesis of NO to abolish the inhibitory effect of NO on tissue metabolism, the tissue metabolism was enhanced (ie, disinhibited) and the total 02 consumption was elevated. It has been demonstrated previously that endogenous NO in supernatant from activated Kupffer cells or exogenous authentic NO resulted in concentration-dependent decreases in 02 consumption in cultured rat hepatocytes.'2"3 Moreover, interferon-y and tumor necrosis factor-a synergistically induced an arginine-dependent production of NO in cultured rat aortic smooth cells that was associated with an inhibition of mitochondrial respiration and tissue 02 consumption and with accumulation of lactate.14 Our results in vivo are consistent with those in vitro stud-ies12-14 and suggest that basal NO production may play an important role in modulating tissue metabolism and 02 consumption under physiological conditions. NO inhibits tissue metabolism most likely through its inhibitory effect on mitochondrial enzymes and regulation of mitochondrial respiration. It has been shown that in murine tumor cell lines, activated macrophages produced NO to inhibit mitochondrial respiration in target cells. In those studies, NO inhibited three mitochondrial enzymes, which were mitochondrial aconitase in the Krebs cycle and NADH+-ubiquinone oxidoreductase and succinate-ubiquinone oxidoreductase (complex I and complex II of the mitochondrial transport chain).9-'4 The mechanism of the inhibitory effect of NO on those mitochondrial enzymes appears to be related to the interaction of NO with intracellular nonheme iron to form nitrosyl-iron complexes and release intracellular iron, which results in the inhibition of dehydrogenases containing an iron-sulfur center.9,24-26
Two types of NO synthase have been identified, and all forms of the enzymes catalyze the conversion of L-arginine to NO and citrulline with NADPH+ as a cofactor. However, one form of NO synthase is Ca 2+/ calmodulin dependent and constitutively expressed in endothelial cells and neurons, whereas a second type of NO synthase is Ca21 independent and is not constitutive but induced after cytokine stimulation in macrophages and other tissues.32728 The NO production associated with the inhibition of energy metabolism and mitochondrial enzymes in all previous studies was related to the inducible type of NO synthase, which needs 4 to 6 hours for activation after exposure to interferon-y and tumor necrosis factor-a, a process thought to be of significance only under pathophysiological conditions. It is important to point out that in the present study a significant elevation of 02 consumption, accompanied by significant increases in arterial pressure and total peripheral resistance and a decrease in cardiac output, occurred almost immediately (within 5 minutes) after intravenous infusion of NLA to block NO synthesis in quietly resting conscious dogs (Figs 1, 2, and 5 ). The immediate onset of this response is most likely due to the inhibitory effect of NLA on the constitutive NO synthesis in endothelium instead of the inhibitory effect on the inducible NO synthase. In a recent study, we found only the constitutive NO synthase in the aortic endothelium of the dog and more recently also failed to find the inducible form of cyclooxygenase, COX II, in normal healthy dogs.28'29 It is also possible that we are inhibiting the constitutive form of NO synthase in cells other than endothelial cells, perhaps in neurons. However, after ganglionic blockade, which should inhibit neuronal release of all transmitters, NLA administration still increased 02 consumption. The exact site of the inhibition of NO synthesis in our studies remains to be determined. Therefore, our data indicate that NO, which is released continuously from vascular endothelium to regulate basal vascular tone, may also play a significant role in the modulation of mitochondrial respiration and cellular metabolism under physiological conditions. This could represent an important function of NO in the signaling between the regulation of tissue blood flow and the regulation of tissue metabolism. NO is constitutively released from vascular endothelium and diffuses to the underlying vascular smooth muscle to regulate vascular tone. 30 This demonstrates that the diffusion distance for NO is not so great as to limit its effect on the nearest cell type, the vascular smooth muscle cell in blood vessels, and perhaps on parenchymal cells close to capillaries in peripheral organs (the heart or skeletal muscle). It should be pointed out that capillaries have the largest surface area of endothelium,31 which most likely releases NO in the vicinity of organ parenchymal cells. NO produced from capillary endothelium could easily diffuse to its parenchymal cells (hepatocytes, muscle cells, etc) to influence cellular 02 consumption and tissue metabolism. In fact, it is well known that tissue metabolic factors such as H+, C02, and adenosine could modulate vascular tone as a feedback mechanism in the regulation of tissue blood flow. On the other hand, the present study indicates a potential role for NO in the regulation of tissue 02 consumption and indicates that NO could be one arm of a negative feedback control mechanism from vessel to tissue.
Because there was an intense vasoconstriction after blockade of NO synthesis by NLA, MTX, an a1-adrenergic agonist, was infused in the present study to determine whether 02 consumption was significantly influenced by vasoconstriction similar in degree to that caused by NLA. The pattern of organ vasoconstriction with MTX is consistent with the known distribution of a-adrenergic receptors. 32, 33 Specifically, the greatest vasoconstriction occurs in skeletal muscle and mesenteric vascular beds,3233 which were also the major sites of vasoconstriction by NLA in our previous studies.20 ,21 In the present study, in which the study animals had about a 30% elevation of mean arterial pressure and total peripheral resistance, MTX caused only a trivial elevation of 02 extraction, accompanied by slight decreases in venous P02 and %O2Hb, a small increase in %RHb in venous blood, and, most importantly, no significant effect on total 02 consumption. This indicates that the total tissue 02 consumption was not significantly affected by vasoconstriction. Thus, in the quietly resting conscious dog, total 02 consumption is determined by tissue metabolism, which is constant. During reduced blood flow as caused by pure vasoconstrictors, eg, MTX in the present study, metabolism is constant and blood flow reduced so that 02 extraction increases without a change in 02 consumption. This, we believe, is precisely the difference between MTX and NLA: both are vasoconstrictors but NLA also possesses a property that results in increased 02 consumption.
Comparing the effects of NLA and MTX on the total 02 consumption associated with similar degrees of hypertension and increase in total peripheral resistance and reductions in cardiac output and heart rate, our results eliminate the possibility that the increase in 02 consumption induced by NLA was simply due to vasoconstriction and a decrease in cardiac output. Instead, it appears that the elevation in 02 consumption resulted directly from the effect of NLA on NO synthase, and our findings strongly suggest that tissue metabolism and 02 consumption are modulated by NO.
NO plays a role in the central nervous system.634, 35 NO synthase has been purified, cloned, sequenced, and expressed in rat brain.6 Administration of NG'monomethyl-L-arginine (L-NMMA) to the rat with total baroreceptor deafferentation elicits an increase in central sympathetic outflow,34 and microinjection of L-NMMA to the nucleus tractus solitarius induces increases in arterial pressure and renal sympathetic nerve activity.35 Therefore, a combination of ganglionic blockade with hexamethonium and atropine was used in the present study to determine whether 02 consumption was significantly influenced by the change of central sympathetic and parasympathetic outflow after NLA administration. After hexamethonium and atropine administration, NLA still caused a significant elevation of total 02 consumption, accompanied by increases in arterial pressure and total peripheral resistance, a decrease in cardiac output, and a constant heart rate. Our results suggest that the elevation of 02 consumption induced by NLA is due to the direct effect of inhibition of NO synthesis, rather than secondary to changes in sympathetic and parasympathetic tone through an effect of NLA on the central nervous system. 
Graphs showing that administration of nitro-L-arginine (NLA) resulted in significant elevations in 02 extraction and 02 consumption for 120 minutes. Administration of methoxamine (MTX) caused only small increases in 02 extraction and had no effect on 02 consumption at any time. All values are mean ±SEM (n=9 in NLA group and n=7 in MTX group). **P<.01 and *P<.05 compared with control.
It should be pointed out that in the present study the elevation of 02 consumption induced by NLA was attenuated by pentobarbital, although all of the hemodynamic changes after NLA, which include increases in arterial pressure and total peripheral resistance and decreases in cardiac output and heart rate, were similar. Barbiturates (eg, amytal) inhibit mitochondrial NADH+ dehydrogenase (complex I) activity and therefore mito- Graph showing that administration of nitro-L-arginine (NLA) caused a significant increase in 02 consumption for 120 minutes in dogs given pretreatment with hexamethonium and atropine (HEXA). In contrast, NLA had no effect on 02 consumption in dogs anesthetized with pentobarbital (PB). All values are mean±SEM (n=5, both groups). *P<.05 compared with before NLA administration. chondrial metabolism by blocking NADH+ oxidation.3637 In anesthetized dogs, although NLA blocked the synthesis of NO in resistance vessels, resulting in the increase in arterial pressure and calculated vascular resistance, the inhibitory effect of barbiturate on mitochondrial enzymes prevented the increase in tissue metabolism and the elevation of 02 consumption. These results further indicate that the mechanism of the modulatory function of NO on tissue metabolism and 02 consumption is due to its inhibitory effects on mitochondrial metabolic enzymes.
In a recent study by King et al,38 inhibition of NO synthase increased 02 consumption in skeletal muscle but had no significant effect on total 02 consumption in pentobarbital-anesthetized dogs. In general, that study supports our conclusions; however, the use of barbiturate anesthesia may have resulted in abolition of the increase in 02 consumption by the whole body and significantly blunted the increase in 02 consumption by skeletal muscle. Thus, the findings of the present study, in which there was a 25+4% increase in whole-body 02 consumption and an increase in body temperature, may indicate the real potential of the physiological control of 02 consumption and mitochondrial function by NO. Furthermore, in those studies nitro-L-arginine methyl ester (L-NAME), which has been shown to act as a muscarinic antagonist,39 was used to inhibit NO synthase. Thus, the effects of L-NAME on 02 consumption by skeletal muscle may involve mechanisms other than blockade of NO synthesis.
